Home NDC 52959-379 DIFLUNISAL
Product NDC 52959-379
11-digit product format 529590379
Labeler code 52959
Product ID 52959-379_60e0ecab-9d00-3b1b-e053-2a91aa0af663
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name DIFLUNISAL
Dosage form TABLET, FILM COATED
Route ORAL
Labeler H. J. Harkins Company Inc.
Application ANDA073673
Marketing category ANDA
Marketing start 2017-12-22
Marketing end 0000-00-00
Substance DIFLUNISAL
Active strength 500 mg/1
Pharmacologic classes Cyclooxygenase Inhibitors [MoA],Anti-Inflammatory Agents, Non-Steroidal [CS],Nonsteroidal Anti-inflammatory Drug [EPC]
NDC exclude flag No
Listing certified through 2019-12-31
Current FDA listing Historical FDA.report record
Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 3 · 168 matching rows.
View current auxiliary records. · View the auxiliary file history.
Source provenance: Browse the complete Orange Book source catalog · source snapshot 45 .
Orange Book products# Current product rows page 1 of 1 · 1 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A073673-001 DIFLUNISAL DIFLUNISAL 500MG TABLET / ORAL AB RS 1992-07-31
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 1 matching rows.
Application-product, TE code table Application-product TE code A073673-001 AB
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 2 · 45 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-11-14 07:37:17 2026-10 A073673-001 DIFLUNISAL 500MG TABLET / ORAL AB RS 1992-07-31 d4dbc9d85df4…2026-10-15 13:18:30 2026-09 A073673-001 DIFLUNISAL 500MG TABLET / ORAL AB RS 1992-07-31 c2088c7a36db…2026-09-14 22:38:34 2026-08 A073673-001 DIFLUNISAL 500MG TABLET / ORAL AB RS 1992-07-31 84e616aacf4f…2026-08-18 06:07:40 2026-07 A073673-001 DIFLUNISAL 500MG TABLET / ORAL AB RS 1992-07-31 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 A073673-001 DIFLUNISAL 500MG TABLET / ORAL AB RS 1992-07-31 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A073673-001 DIFLUNISAL 500MG TABLET / ORAL AB RS 1992-07-31 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 A073673-001 DIFLUNISAL 500MG TABLET / ORAL AB RS 1992-07-31 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A073673-001 DIFLUNISAL 500MG TABLET / ORAL AB RS 1992-07-31 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A073673-001 DIFLUNISAL 500MG TABLET / ORAL AB RS 1992-07-31 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A073673-001 DIFLUNISAL 500MG TABLET / ORAL AB RS 1992-07-31 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A073673-001 DIFLUNISAL 500MG TABLET / ORAL AB RS 1992-07-31 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A073673-001 DIFLUNISAL 500MG TABLET / ORAL AB RS 1992-07-31 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A073673-001 DIFLUNISAL 500MG TABLET / ORAL AB RS 1992-07-31 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 A073673-001 DIFLUNISAL 500MG TABLET / ORAL AB RS 1992-07-31 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 A073673-001 DIFLUNISAL 500MG TABLET / ORAL AB RS 1992-07-31 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 A073673-001 DIFLUNISAL 500MG TABLET / ORAL AB RS 1992-07-31 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 A073673-001 DIFLUNISAL 500MG TABLET / ORAL AB RS 1992-07-31 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 A073673-001 DIFLUNISAL 500MG TABLET / ORAL AB RS 1992-07-31 8072bd15b7f6…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 A073673-001 DIFLUNISAL 500MG TABLET / ORAL AB RS 1992-07-31 5c6f7cd8ea54…2022-04-08 23:34 UTC 2022-04 A073673-001 DIFLUNISAL 500MG TABLET / ORAL AB RS 1992-07-31 5d02ea3f76ae…2022-04-04 05:41 UTC 2022-04 A073673-001 DIFLUNISAL 500MG TABLET / ORAL AB RS 1992-07-31 4b0b4de00fa7…2019-12-13 00:20 UTC 2019-12 A073673-001 DIFLUNISAL 500MG TABLET / ORAL AB RS 1992-07-31 74a2ff9319b5…2022-03-09 01:35 UTC 2022-03 A073673-001 DIFLUNISAL 500MG TABLET / ORAL AB RS 1992-07-31 bb7c543d1eb4…2021-12-28 21:50 UTC 2021-12 A073673-001 DIFLUNISAL 500MG TABLET / ORAL AB RS 1992-07-31 782e0a99824c…2021-05-05 16:15 UTC · 3 captures of this ZIP 2021-05 A073673-001 DIFLUNISAL 500MG TABLET / ORAL AB RS 1992-07-31 87673890dc5c…2021-03-12 10:30 UTC 2021-03 A073673-001 DIFLUNISAL 500MG TABLET / ORAL AB RS 1992-07-31 5aa47cf7b7d7…2020-12-22 03:56 UTC 2020-12 A073673-001 DIFLUNISAL 500MG TABLET / ORAL AB RS 1992-07-31 8869cabd3fbd…2020-11-12 02:37 UTC 2020-11 A073673-001 DIFLUNISAL 500MG TABLET / ORAL AB RS 1992-07-31 c0c555d07b60…2019-12-14 00:12 UTC 2019-12 A073673-001 DIFLUNISAL 500MG TABLET / ORAL AB RS 1992-07-31 3f01610625f2…2019-09-15 20:21 UTC 2019-09 A073673-001 DIFLUNISAL 500MG TABLET / ORAL AB RS 1992-07-31 b00525d2431f…2019-07-19 19:46 UTC 2019-07 A073673-001 DIFLUNISAL 500MG TABLET / ORAL AB RS 1992-07-31 ea99ee380514…2024-03-16 18:09 UTC · 4 captures of this ZIP 2024-03 A073673-001 DIFLUNISAL 500MG TABLET / ORAL AB RS 1992-07-31 6a51e52b5d6a…2024-02-18 07:12 UTC 2024-02 A073673-001 DIFLUNISAL 500MG TABLET / ORAL AB RS 1992-07-31 1c564ffb4f44…2023-12-20 04:57 UTC 2023-12 A073673-001 DIFLUNISAL 500MG TABLET / ORAL AB RS 1992-07-31 ea1830bbd6c7…2023-11-28 05:40 UTC · 2 captures of this ZIP 2023-11 A073673-001 DIFLUNISAL 500MG TABLET / ORAL AB RS 1992-07-31 a72a2bbeb626…2023-10-25 00:34 UTC · 2 captures of this ZIP 2023-10 A073673-001 DIFLUNISAL 500MG TABLET / ORAL AB RS 1992-07-31 9b2671bbb829…2023-07-15 15:27 UTC · 2 captures of this ZIP 2023-07 A073673-001 DIFLUNISAL 500MG TABLET / ORAL AB RS 1992-07-31 a67488948f0b…2023-06-13 01:57 UTC · 3 captures of this ZIP 2023-06 A073673-001 DIFLUNISAL 500MG TABLET / ORAL AB RS 1992-07-31 3f0d92c62455…2023-05-13 08:27 UTC 2023-05 A073673-001 DIFLUNISAL 500MG TABLET / ORAL AB RS 1992-07-31 053a50430f4f…2023-01-26 05:58 UTC 2023-01 A073673-001 DIFLUNISAL 500MG TABLET / ORAL AB RS 1992-07-31 3bdfa0b2c4d7…
Observed Orange Book normalized TE history# Normalized TE history page 2 of 2 · 45 observed states.
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed Product Concepts# FDA-Initiated Inactive NDC Indexing# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 52959-379-14 DIFLUNISAL 14 in 1 CONTAINER TABLET, FILM COATED 14 1 52959-379-15 DIFLUNISAL 15 in 1 CONTAINER TABLET, FILM COATED 15 1 52959-379-20 DIFLUNISAL 20 in 1 CONTAINER TABLET, FILM COATED 20 1 52959-379-21 DIFLUNISAL 21 in 1 CONTAINER TABLET, FILM COATED 21 1 52959-379-30 DIFLUNISAL 30 in 1 CONTAINER TABLET, FILM COATED 30 1 52959-379-60 DIFLUNISAL 60 in 1 CONTAINER TABLET, FILM COATED 60 1 52959-379-90 DIFLUNISAL 90 in 1 CONTAINER TABLET, FILM COATED 90 1
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 52959-379 DIFLUNISAL TABLET, FILM COATED [H. J. HARKINS COMPANY INC.] 1 Legacy NDC, 7 package rows 20171222_60e0ecab-9cff-3b1b-e053-2a91aa0af663.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Brand, Generic, Manufacturer table Brand Generic Manufacturer SPL set ID Effective date Available safety fields Join Diflunisal DIFLUNISAL Teva Pharmaceuticals USA, Inc. 7a78bb38-14d8-4a90-b883-482d4cebf716 2024-07-16 Boxed warning, Warnings, Adverse reactions Exact identifier application applno (ANDA): 073673 application number: ANDA073673
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Status 52959-379-14 52959037914 14 in 1 CONTAINER Historical 52959-379-15 52959037915 15 in 1 CONTAINER Historical 52959-379-20 52959037920 20 in 1 CONTAINER Historical 52959-379-21 52959037921 21 in 1 CONTAINER Historical 52959-379-30 52959037930 30 in 1 CONTAINER Historical 52959-379-60 52959037960 60 in 1 CONTAINER Historical 52959-379-90 52959037990 90 in 1 CONTAINER Historical